We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Single-incision laparoscopic reversal of Hartmann procedure via the colostomy site only: first report.
Surgical Innovation 2011 December
BACKGROUND: Transumbilical single-incision laparoscopic surgery (SILS) provides an alternative to traditional multiport laparoscopic surgery. The technique may also avoid some of the difficulties surrounding laparoscopic Hartmann reversal. This case represents the first SILS Hartmann reversal via the colostomy site.
METHODS: SILS Hartmann reversal was performed in a 56-year-old man with a history of resection for perforated diverticulitis. The procedure was performed via a single port placed into the former colostomy site. A combination of flexible and straight instruments was used.
RESULTS: The procedure was completed successfully with an operative time of 104 minutes. Recovery was uneventful, and the patient was discharged on postoperative day 5, with no complaints at follow-up.
CONCLUSION: SILS Hartmann procedure reversal via the colostomy site is safe. The approach avoids additional incisions and allows avoidance of dense adhesions to the previous midline incision--a new benefit of SILS, apart from cosmesis.
METHODS: SILS Hartmann reversal was performed in a 56-year-old man with a history of resection for perforated diverticulitis. The procedure was performed via a single port placed into the former colostomy site. A combination of flexible and straight instruments was used.
RESULTS: The procedure was completed successfully with an operative time of 104 minutes. Recovery was uneventful, and the patient was discharged on postoperative day 5, with no complaints at follow-up.
CONCLUSION: SILS Hartmann procedure reversal via the colostomy site is safe. The approach avoids additional incisions and allows avoidance of dense adhesions to the previous midline incision--a new benefit of SILS, apart from cosmesis.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app